Hans Kierstead, CEO and founder of Aivita Biomedical, Speaks to Tristan Free, Digital Editor of BioTechniqes. Hans delves into his company's exciting new precision immunotherapy, currently undergoing phase II trials and discusses his 2018 run for US Congress, explaining why he is passionate about the need for scientists in politics.
view more